NL-OMON20298招募中不适用
Phase I, randomized, placebo controlled, double blind, single dose-escalating study assessing the safety, tolerability, pharmacokinetics and pharmacodynamics of intravenous IQNLF in healthy subjects.
IQ TherapeuticsRozenburglaan 13a9727 DL GroningenThe Netherlands0 个研究点目标入组 32 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 32
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Male or female subjects;
- •2. Aged between 18 and 55;
排除标准
- •1. History of any (investigational) anthrax therapy;
- •2. Excessive alcohol consumption;
研究者
相似试验
已完成
不适用
Phase 1, randomized, placebo controlled, double blind, single dose-escalation study assessing the safety, tolerability, pharmacokinetics and pharmacodynamics of intravenous IQNLF in healthy subjects.Bacillus anthracis10004018AnthraxNL-OMON36585IQ Therapeutics36
已完成
1 期
Phase 1, Randomized, Placebo-controlled, Double-blind, Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD) Study to Evaluate the Safety, Tolerability and Pharmacokinetics of NB-4746 in Healthy VolunteersAmyotrophic lateral sclerosis (ALS)Neurological - Neurodegenerative diseasesACTRN12623000476639ura Bio Inc.52
招募中
1 期
Phase 1b clinical trial testing whether cimetidine prevents hearing loss from cisplatin chemotherapy in head and neck cancer patientsChemotherapy toxicityCancer - Head and neckEar - DeafnessNeurological - Other neurological disordersRenal and Urogenital - Kidney diseaseACTRN12618000877280Associate Professor Michael Jameson30
已完成
1 期
Phase I study of oral artesunate in colorectal cancerColorectal adenocarcinomaMalignant neoplasm of colonCancerISRCTN05203252St George's, University of London (UK)22
已完成
1 期
Study in healthy volunteers of the safety and how the body handles PCN-101Mental Health - DepressionDepressionACTRN12620000226909PERCEPTION NEUROSCIENCE, INC.58